FI913049A0 - Foerhindrande kopplingsmedel och foerfaranden. - Google Patents

Foerhindrande kopplingsmedel och foerfaranden.

Info

Publication number
FI913049A0
FI913049A0 FI913049A FI913049A FI913049A0 FI 913049 A0 FI913049 A0 FI 913049A0 FI 913049 A FI913049 A FI 913049A FI 913049 A FI913049 A FI 913049A FI 913049 A0 FI913049 A0 FI 913049A0
Authority
FI
Finland
Prior art keywords
kopplingsmedel
foerhindrande
och foerfaranden
foerfaranden
och
Prior art date
Application number
FI913049A
Other languages
English (en)
Finnish (fi)
Inventor
Stephen Fitzhugh Carroll
Dane A Goff
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Publication of FI913049A0 publication Critical patent/FI913049A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Dental Preparations (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI913049A 1988-12-22 1991-06-20 Foerhindrande kopplingsmedel och foerfaranden. FI913049A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28858688A 1988-12-22 1988-12-22
PCT/US1989/005789 WO1990006774A1 (en) 1988-12-22 1989-12-21 Hindered linking agents and methods

Publications (1)

Publication Number Publication Date
FI913049A0 true FI913049A0 (fi) 1991-06-20

Family

ID=23107753

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913049A FI913049A0 (fi) 1988-12-22 1991-06-20 Foerhindrande kopplingsmedel och foerfaranden.

Country Status (10)

Country Link
US (1) US5093475A (da)
EP (1) EP0454726A4 (da)
JP (1) JPH04502469A (da)
KR (1) KR910700242A (da)
AU (1) AU645745B2 (da)
CA (1) CA2006629A1 (da)
DK (1) DK121691D0 (da)
FI (1) FI913049A0 (da)
NZ (2) NZ241869A (da)
WO (1) WO1990006774A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563250A (en) * 1987-12-02 1996-10-08 Neorx Corporation Cleavable conjugates for the delivery and release of agents in native form
US6552170B1 (en) * 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US5169754A (en) * 1990-10-31 1992-12-08 Coulter Corporation Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same
DE4101394A1 (de) * 1991-01-18 1992-07-23 Medor Lab Fuer Biochemie Und K Verfahren zum koppeln von kohlenhydraten an traeger, insbesondere proteine
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
US6146850A (en) * 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5621083A (en) 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5648218A (en) * 1993-02-12 1997-07-15 Sealite Sciences, Inc. Preparation of photoprotein conjugates and methods of use thereof
DE69430523T2 (de) * 1993-02-12 2002-11-28 Sealite Sciences, Inc. Herstellung von photoprotein konjugaten und verfahren zu ihrer verwendung
US5565200A (en) * 1995-04-14 1996-10-15 University Of Southern California Pharmaceutical preparations derived from korean mistletoe
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
US5547674A (en) * 1995-04-14 1996-08-20 University Of Southern California Pharmaceutical preparations derived from European mistletoe
TW555765B (en) * 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
US6660843B1 (en) * 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
WO2000059545A1 (en) * 1999-04-07 2000-10-12 The Horticulture And Food Research Institute Of New Zealand Limited Modification of sexual behaviour in animals and pest control
US7723118B2 (en) * 2002-10-18 2010-05-25 Alt Bioscience, Llc. Compositions and methods for simultaneous detection of volatile sulfur compounds and polyamines
US8492129B2 (en) * 2005-12-12 2013-07-23 Innova Biosciences, Ltd. Production of conjugates
EP2243029B1 (en) * 2008-06-13 2014-12-24 Alt Bioscience, Llc. Device for rapid determination of disease-associated thiol compounds
FR2947269B1 (fr) 2009-06-29 2013-01-18 Sanofi Aventis Nouveaux composes anticancereux
FR2963007B1 (fr) 2010-07-26 2013-04-05 Sanofi Aventis Derives anticancereux, leur preparation et leur application therapeutique

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3348940A (en) * 1963-12-05 1967-10-24 American Cyanamid Co Herbicidal and insecticidal composition
US3318910A (en) * 1963-12-05 1967-05-09 American Cyanamid Co 2-iminothiolanes and related compounds
US3317562A (en) * 1965-02-23 1967-05-02 American Cyanamid Co 2-oximinothiolanes and related compounds
US3755364A (en) * 1972-02-02 1973-08-28 Diamond Shamrock Corp 3-(n-carbamyloximino)-saturated thioheterocyclic compounds
US4590071A (en) * 1984-09-25 1986-05-20 Xoma Corporation Human melanoma specific immunotoxins
DE3581210D1 (de) * 1985-03-04 1991-02-07 Dana Farber Cancer Inst Inc Immunotoxin und herstellung.
US4888415A (en) * 1985-03-04 1989-12-19 Dana-Farber Cancer Institute, Inc. Gelonin immunotoxin
US4880935A (en) * 1986-07-11 1989-11-14 Icrf (Patents) Limited Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
IL89222A (en) * 1988-02-09 1995-03-30 Mallinckrodt Inc Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteins

Also Published As

Publication number Publication date
DK121691A (da) 1991-06-21
NZ241869A (en) 1992-07-28
DK121691D0 (da) 1991-06-21
WO1990006774A1 (en) 1990-06-28
EP0454726A1 (en) 1991-11-06
CA2006629A1 (en) 1990-06-22
KR910700242A (ko) 1991-03-14
NZ231988A (en) 1992-04-28
AU4849190A (en) 1990-07-10
EP0454726A4 (en) 1991-11-27
US5093475A (en) 1992-03-03
AU645745B2 (en) 1994-01-27
JPH04502469A (ja) 1992-05-07

Similar Documents

Publication Publication Date Title
FI892567A (fi) Benzopyranderivat och foerfarande foer deras framstaellning.
FI880206A0 (fi) Tryckgivarkonstruktion och foerfarande foer framstaellning daerav.
FI890622A0 (fi) Elektriskt ledande polymerer och deras framstaellning.
FI885606A (fi) Banformningsfoerfarande och anordning.
FI913049A0 (fi) Foerhindrande kopplingsmedel och foerfaranden.
FI880298A0 (fi) Testanordning foer fordonsdaeck och slirskydd.
FI892235A (fi) Foerbaettringar betraeffande foerfarande och anordning foer registrering.
FI882761A (fi) Punktventilationsfoerfarande och punktventilationsanordning foer arbetspunkt.
FI891560A (fi) Mottagare och en foer denna mottagare laemplig demoduleringskrets.
FI884001A (fi) Siltrumma och foerfarande foer framstaellning daerav.
FI891304A (fi) Kefalosprinderivat och deras framstaellningsfoerfarande.
FI892293A0 (fi) Boejbestaendiga polyesterfilament och deras framstaellning och anvaendning.
FI881066A0 (fi) Foerfarande och anordning foer luftrening.
FI884002A0 (fi) Silplaot och foerfarande foer framstaellning daerav.
FI883519A (fi) Tappspaerrsylinderlaos och nyckel.
FI881352A (fi) Kosmetiska ljusskyddsaemnen och foerfarande foer deras framstaellning.
FI880828A (fi) Reningsverk foer oljehaltigt och avfallsvatten.
FI882762A0 (fi) Punktventilationsfoerfarande och punktventilationsanordning.
FI880484A0 (fi) Loesflak och lastvaexlare.
FI884024A (fi) Fraemre och bakre stoetfaongare foer fordon.
FI883295A (fi) Kombinerad stoedmede och saettbill foer en potatissaettare.
FI883332A0 (fi) Foerfarande foer torvbehandling och torvmaskin.
FI884257A0 (fi) Sugborr och sugborste.
FI884393A (fi) Gipsstenfria cementblandningar och foerfarande foer deras framstaellning.
FI884664A (fi) Pappersprodukt innehaollande latexpartiklar och foerfarande foer framstaellning daerav.